Emerging Markets
Emerging markets face unique challenges in accessing medicines and medical technologies.
Forecasting the Challenges and Economics of Drug Development in 2022
9 July 2013
A new publication from the Office of Health Economics captures the views of thought leaders from around the world about the scientific and economic climate for…
Can lessons from valuing health be useful in valuing development aid?
25 March 2012
Measuring and evaluating the impact of development aid is a perennial challenge. Various approaches have been tried. Since many have been aimed at donor needs and…
Spotlight on OHE: Assessing Value and Balancing Needs in Health Care
15 December 2011
During the last quarter of 2011, OHE team members were involved in discussions and presentations in a range of forums, covering each of OHE’s three areas…
Spotlight on OHE: Measuring Preferences, HTA Benchmarking, Value-Based Pricing, and Rationing
13 October 2011
This post reviews OHE’s activities in September 2011 that contributed to advancing thought and stimulating innovative ideas in its three key research areas: financing and delivery…
OHE in the Spotlight: Summer 2011
22 September 2011
This is the first in a series of posts that will review OHE’s contributions to advancing thought and stimulating innovative ideas in its three key research…
HTA and Appropriate Drug Pricing Worldwide
9 September 2011
The August 2011 issue of Health Affairs featured four articles on how and why pricing for pharmaceuticals differs from one country to another. The OHE’s Prof…
Incentives for R&D for New Antimicrobial Drugs
31 August 2011
Just published by OHE researchers is a comprehensive analysis of what policy measures are needed to counter the growing global problem of antimicrobial resistance. Their key…
Pricing in Emerging Markets: Income, Competition and Procurement
16 August 2011
Most patients in middle and low income countries (MLICs) lack insurance coverage and so pay out of pocket for prescription medicines; pricing commensurate with income thus…
The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response
1 January 2011
This report examines and makes suggestions for the appropriate use of health technology assessment (HTA) in emerging markets. In particulary, it considers how the stage of development…